NCT04748861View on ClinicalTrials.gov

CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease)

NAActive, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
High Intensity ExerciseNormal CognitionExercise Intervention
Interventions
OTHER

Indoor Cycling (IC)

Participants will ride a Peloton bike 3x/week for 18 months.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

University of Maryland, College Park

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

The Cleveland Clinic

OTHER

NCT04748861 - CYCLE-AD (CYcling to Cease or Limit the Effects of Alzheimer's Disease) | Biotech Hunter | Biotech Hunter